Company Monitoring Page for Vivus

latest headlines for company on cafepharma

Reimbursement battle for Qsymia hits Vivus figures
Pharma Times, UK
Tue, 02/26/13 - 10:55 am
Tags:
Vivus, reimbursement, Qsymia
VIVUS Earnings: Here’s Why Investors are Not Excited Now
Wall St. Cheat Sheet
Tue, 02/26/13 - 10:33 am
Tags:
earnings, Vivus
This Week in Biotech
Motley Fool
Sun, 02/24/13 - 02:20 pm
Tags:
Roche, Immunogen, Repros Therapeutics, Chelsea Therapeutics, Gilead Sciences, Vivus
Vivus, Inc.: Second Rejection And Upcoming Earnings, Patience Required For Investors
Seeking Alpha
Fri, 02/22/13 - 11:37 am
Tags:
Vivus, earnings, Qsymia
CHMP rejects Vivus diet pill again
Pharma Times, UK
Fri, 02/22/13 - 10:45 am
Tags:
Vivus, Europe, Qsiva, Qsymia
This Obesity Bet Just Became More Attractive
Motley Fool
Wed, 02/13/13 - 10:43 am
Tags:
obesity, Vivus, Pfizer, Qsymia, Arena Pharmaceuticals
Slow and steady can win the diet drug race: Vivus' launch of Belviq
Reuters
Fri, 02/8/13 - 11:17 am
Tags:
Vivus, Belviq, obesity, drug launches
EnteroMedics: Fat Zapper or Pulsing Placebo?
TheStreet.com
Wed, 02/6/13 - 08:37 am
Tags:
EnteroMedics, Vivus, Arena Pharmaceuticals, Vbloc
Vivus up on heart drug study
Investors Business Daily
Sat, 02/2/13 - 11:44 am
Tags:
Vivus, Qsymia, Anti-Hypertension
Vivus Stock Up On Qsymia Heart Disease Study
Investors.com
Fri, 02/1/13 - 11:38 am
Tags:
Vivus, Qsymia
The Obesity Epidemic: EnteroMedics' New Treatment Approach
Seeking Alpha
Tue, 01/29/13 - 11:09 am
Tags:
obesity, EnteroMedics, Acadia, Vivus, Orexigen, Arena Pharmaceuticals
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Sun, 01/27/13 - 11:18 am
Tags:
Theravance, GSK, Astellas, Vivus, Eli Lilly, Immunogen, Roche, M&A
Vivus: Today's Featured Drugs Laggard
The Street
Sat, 01/26/13 - 11:45 am
Tags:
Vivus
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Fri, 01/25/13 - 10:39 am
Tags:
Vivus, Theravance, Roche, MAP Pharmaceuticals, M&A, Immunogen, GSK, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Allergan
The Biggest Loser in the Obesity Drug Market
Motley Fool
Fri, 01/18/13 - 09:20 am
Tags:
obesity, Vivus, Qsymia, Belviq, Arena Pharmaceuticals, Orexigen, Contrave
Will Qsymia's Stellar Sales Growth Continue?
Motley Fool
Fri, 01/11/13 - 12:15 pm
Tags:
Vivus, Qsymia, obesity
4 Biotechnology Stocks With Upcoming Catalysts
Seeking Alpha
Wed, 01/9/13 - 10:06 am
Tags:
Vivus, Peregrine Pharmaceuticals, JNJ, Cellceutix
Vivus obesity pill prescriptions jump 68 percent, shares rise
Reuters
Mon, 01/7/13 - 10:39 am
Tags:
Vivus, obesity, Qsymia
Upcoming Catalysts For Vivus
Seeking Alpha
Fri, 01/4/13 - 11:41 am
Tags:
Vivus, Qsymia
And the Obesity Plot Thickens
Motley Fool
Wed, 01/2/13 - 11:58 am
Tags:
obesity, Vivus, Arena Pharmaceuticals, Roche, Orexigen, mimAb1, Amgen, Zafgen, Belviq, Qsymia, beloranib, Contrave

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.